Your browser doesn't support javascript.
loading
A beacon in the dark: COVID-19 course in CVID patients from two European countries: Different approaches, similar outcomes.
Milito, Cinzia; Firinu, Davide; Bez, Patrick; Villa, Annalisa; Punziano, Alessandra; Lagnese, Gianluca; Costanzo, Giulia; van Leeuwen, Leanne P M; Piazza, Beatrice; Deiana, Carla Maria; d'Ippolito, Giancarlo; Del Giacco, Stefano Renato; Rattazzi, Marcello; Spadaro, Giuseppe; Quinti, Isabella; Scarpa, Riccardo; Dalm, Virgil A S H; Cinetto, Francesco.
Afiliação
  • Milito C; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
  • Firinu D; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • Bez P; Rare Diseases Referral Center, Internal Medicine 1, Ca' Foncello Hospital, AULSS2 Marca Trevigiana, Department of Medicine (DIMED), University of Padova, Padova, Italy.
  • Villa A; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
  • Punziano A; Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.
  • Lagnese G; Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.
  • Costanzo G; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • van Leeuwen LPM; Department of Viroscience, Travel Clinic, Erasmus University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Piazza B; Rare Diseases Referral Center, Internal Medicine 1, Ca' Foncello Hospital, AULSS2 Marca Trevigiana, Department of Medicine (DIMED), University of Padova, Padova, Italy.
  • Deiana CM; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • d'Ippolito G; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
  • Del Giacco SR; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • Rattazzi M; Rare Diseases Referral Center, Internal Medicine 1, Ca' Foncello Hospital, AULSS2 Marca Trevigiana, Department of Medicine (DIMED), University of Padova, Padova, Italy.
  • Spadaro G; Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.
  • Quinti I; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
  • Scarpa R; Rare Diseases Referral Center, Internal Medicine 1, Ca' Foncello Hospital, AULSS2 Marca Trevigiana, Department of Medicine (DIMED), University of Padova, Padova, Italy.
  • Dalm VASH; Department of Internal Medicine, Division of Allergy and Clinical Immunology, Department of Immunology, Erasmus University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Cinetto F; Rare Diseases Referral Center, Internal Medicine 1, Ca' Foncello Hospital, AULSS2 Marca Trevigiana, Department of Medicine (DIMED), University of Padova, Padova, Italy.
Front Immunol ; 14: 1093385, 2023.
Article em En | MEDLINE | ID: mdl-36845159
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article